Stock Events

Stock Events

Innovation Pharmaceuticals 

$0.000300
9
+$0.00+50% Monday 15:39

Statistics

Day High
0.0003
Day Low
0.0002
52W High
0.05
52W Low
0.00001
Volume
421,598
Avg. Volume
-
Mkt Cap
155,504.4
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Sep 17
$0.44
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

10NovExpected
Q3 2020
Q4 2020
Q1 2021
Q3 2021
Q4 2021
Q1 2022
Q3 2022
-0.02
-0.01
-0.01
-0
Expected EPS
N/A
Actual EPS
-0.0028

Financials

-Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
0Revenue
548,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IPIX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap294.03B
Merck & Co., Inc. is a global healthcare company that develops medications in areas similar to Innovation Pharmaceuticals, making them direct competitors in the pharmaceutical market.
Pfizer
PFE
Mkt Cap149.38B
Pfizer Inc. operates in the same industry, developing and producing drugs and vaccines, including treatments that may overlap with Innovation Pharmaceuticals' research areas.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson is a broad healthcare company that, through its pharmaceutical division, competes in developing treatments that could be in direct competition with Innovation Pharmaceuticals' product pipeline.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie Inc. focuses on pharmaceuticals including immunology and oncology, areas that might intersect with Innovation Pharmaceuticals' research and development, making them competitors.
Gilead Sciences
GILD
Mkt Cap155.93B
Gilead Sciences, Inc. specializes in antiviral drugs for infectious diseases, an area that could overlap with Innovation Pharmaceuticals' focus, especially if they are working on similar treatments.
AMGEN
AMGN
Mkt Cap191.7B
Amgen Inc. is a biopharmaceutical company that develops innovative medicines, potentially in competition with Innovation Pharmaceuticals, especially in the areas of oncology and inflammation.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol-Myers Squibb Company is involved in discovering, developing, and delivering innovative medicines that address serious diseases, possibly in competition with Innovation Pharmaceuticals' projects.
Novartis
NVS
Mkt Cap292.07B
Novartis AG is a global healthcare company that operates in various therapeutic areas, some of which may directly compete with Innovation Pharmaceuticals' research and development focus.
Roche
RHHBY
Mkt Cap332.67B
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses worldwide, with a broad product portfolio that could compete with Innovation Pharmaceuticals in multiple areas.
Astrazeneca
AZN
Mkt Cap277.22B
AstraZeneca PLC is a biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, potentially competing with Innovation Pharmaceuticals in several therapeutic areas.

About

Innovation Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to the development of small molecule therapies. Its pipeline targets a range of medical areas, including inflammatory diseases, cancer, dermatology, and infectious conditions. The company's lead drug candidate, Brilacidin, is currently in development for treating oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. Furthermore, Innovation Pharmaceuticals is advancing Kevetrin, an anti-cancer compound being investigated for ovarian cancer. The company holds a license agreement with Alfasigma S.p.A. and has a collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. Established in 2005 and headquartered in Wakefield, Massachusetts, the firm operated as Cellceutix Corporation until its name change to Innovation Pharmaceuticals Inc. in June 2017.
Show more...
CEO
Mr. Leo Ehrlich CPA
Employees
4
Country
United States
ISIN
US45782D1000

Listings

OTC Link
US
IPIX

0 Comments

Share your thoughts

FAQ

What is Innovation Pharmaceuticals stock price today?▼
The current price of IPIX is $0.00 USD — it has increased by +50% in the past 24 hours. Watch Innovation Pharmaceuticals stock price performance more closely on the chart.
What is Innovation Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Innovation Pharmaceuticals stocks are traded under the ticker IPIX.
What is Innovation Pharmaceuticals market cap?▼
Today Innovation Pharmaceuticals has the market capitalization of 155,504.4
What were Innovation Pharmaceuticals earnings last quarter?▼
IPIX earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Innovation Pharmaceuticals revenue for the last year?▼
Innovation Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Innovation Pharmaceuticals net income for the last year?▼
IPIX net income for the last year is 548,000 USD.
How many employees does Innovation Pharmaceuticals have?▼
As of June 16, 2026, the company has 4 employees.
In which sector is Innovation Pharmaceuticals located?▼
Innovation Pharmaceuticals operates in the Health & Wellness sector.
When did Innovation Pharmaceuticals complete a stock split?▼
Innovation Pharmaceuticals has not had any recent stock splits.
Where is Innovation Pharmaceuticals headquartered?▼
Innovation Pharmaceuticals is headquartered in Wakefield, United States.